Europe Nuclear Medicine Radiopharmaceuticals Market by Diagnostics (SPECT, PET), by Therapeutics (Beta Emitters, Alpha Emitters, Brachytherapy), by Application (cardiology, lymphoma, thyroid, neurology oncology) and by Region - Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

Europe Nuclear Medicine Radiopharmaceuticals Market by Diagnostics (SPECT, PET), by Therapeutics (Beta Emitters, Alpha Emitters, Brachytherapy), by Application (cardiology, lymphoma, thyroid, neurology oncology) and by Region - Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

ID: 131 | Pages: 140 | December 2016 | Region: Europe


The Europe market for nuclear medicine Radiopharmaceuticals is estimated at $1040 million in 2015 and is expected to reach $1780 million by 2020, growing at a CAGR of 11.4%. Nuclear medicine falls under the field of Molecular imaging, which involves usage of minute amount of radioactive material (radiopharmaceuticals) to diagnose and treat disease.

Increasing prevalence of chronic diseases such as cancer and cardiac ailments, rapid technological advancements, increasing demand for SPECT and PET applications and the growing public awareness for healthcare are fuelling the market growth for Radiopharmaceuticals. Further, Integration of X ray tomography (CT) into SPECT has emerged as an excellent diagnostic tool in the medical imaging and is considered to be a driving factor for the growth of the market. Strict regulatory framework pose as a great hurdle to translational research & clinical investigations and reimbursement issues are blocking the growth of the market. In addition, shorter half-life of radiopharmaceuticals and competition from orthodox diagnostic procedures are the key factors restraining the Europe nuclear medicine Radioisotopes market.

The market of radiopharmaceuticals is segmented into Diagnostic radioisotopes and Therapeutic radioisotopes. Diagnostic radioisotope market basically covers SPECT (Technetium-99m, Thallium-201 Gallium-67, Iodine) and PET (Fluorine-18, Rubidium-82) radioisotopes. Therapeutic radioisotopes cover Beta emitters (Iodine-131, Yttrium-90, Samarium-153, Rhenium-186, Lutetium-177), Alpha Emitters (Radium-223) and Brachytherapy (Cesium-131, Iodine-125, Palladium-103, Iridium-192). By application market is segmented into (cardiology, lymphoma, thyroid, neurology oncology, and others). Furthermore, on the basis of geography, the European Market is segmented into various regions namely UK, Spain, Italy, Germany and France.

Radiopharmaceuticals market is dominated by diagnostic radioisotopes with a market share of 90 % while therapeutic radioisotopes contribute a minor share of around 10% of the market. Based on type of radioisotopes the market is segmented into Technetium-99m (TC-99m), Thallium-201 (TL-201), Fluorine-18,Iodine (I-123), Rubidium-82 (RB-82) and others. The F-18 market is mostly contributed by F-18 FDG tracers though this market is enriched with future tracers such as F-18 Florbetapir and F-18 Choline. The promising clinical outcomes of these tracers have been gaining the business interest of major research institutes and PET isotope players. Ga-68 and Rb-82 are two new potential isotopes in the PET diagnostic market, ensuring high growth of the diagnostics segment. Diagnosis of coronary artery disease, bone metastasis, and Alzheimer’s disease are the most promising indications for the future PET radioisotopes market.

Some of the key players influencing the Europe nuclear medicine market are GE Healthcare, Hologic Inc., Medix Inc., Segami Corporation,Positron Corporation,Bracco Imaging S.p.A, Naviscan Inc., Bayer Healthcare, Lantheus Medical Imaging, Inc. and IBA Molecular Imaging.

1.Introduction                                                  

                1.1 Market Definition                                    

                1.2 Study Deliverables                                  

                1.3 Base Currency, Base Year and Forecast Periods                                           

                1.4 General Study Assumptions                                

2. Research Methodology                                                           

                2.1 Introduction                                              

                2.2 Analysis Design                                         

                2.3 Research Phases                                      

                                2.3.1 Secondary Research                            

                                2.3.2 Primary Research                 

                                2.3.3 Econometric Modelling                     

                                2.3.4 Expert Validation                  

                2.4 Study Timeline                                          

3. Overview                                                      

                3.1 Executive Summary                                

                3.2 Key Inferences                                         

                3.3 New Developments                                

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                      

                4.1 Market Drivers                                          

                4.2 Market Restraints                                    

                4.3 Key Challenges                                         

                4.4 Current Opportunities in the Market                               

5. Market Segmentation                                                              

                5.1 By Type                                        

                                5.1.1 Diagnostic Radioisotopes                 

                                                5.1.1.1 SPECT    

                                                                5.1.1.1.1 Technetium-99m

                                                                5.1.1.1.2 Thallium-201

                                                                5.1.1.1.3 Gallium-67

                                                                5.1.1.1.4 Iodine-23

                                                                5.1.1.1.5 Others

                                                5.1.1.2 PET         

                                                                5.1.1.2.1 Fluorine-18

                                                                5.1.1.2.2 Rubidium-82

                                                                5.1.1.2.3 Others

                                5.1.2 Therapeutic Radioisotopes                              

                                                5.1.2.1 Beta Emitters     

                                                                5.1.2.1.1 Iodine-131

                                                                5.1.2.1.2 Yttrium-90

                                                                5.1.2.1.3 Samarium-153

                                                                5.1.2.1.4 Rhenium-186

                                                                5.1.2.1.5 Lutetium-177

                                                5.1.2.2 Alpha Emitters   

                                                                5.1.2.2.1 Radium-223

                                                5.1.2.3 Brachytherapy   

                                                                5.1.2.3.1 Cesium-131

                                                                5.1.2.3.2 Iodine-125

                                                                5.1.2.3.3 Palladium-103

                                                                5.1.2.3.4 Iridium-192

                5.2 By Application                                           

                                5.2.1 Cardiology                               

                                5.2.2 Lymphoma                             

                                5.2.3 Thyroid                     

                                5.2.4 Neurology               

                                5.2.5 Oncology                 

                                5.2.6 Others                      

6. Geographical Analysis                                                              

                6.1 Introduction                                              

                6.2 U.K                                

                6.3 Spain                                             

                6.4 Germany                                     

                6.5 Italy                                               

                6.6 France                                          

7.Strategic Analysis                                                        

                7.1 PESTLE analysis                                         

                                7.1.1 Political                     

                                7.1.2 Economic                 

                                7.1.3 Social                         

                                7.1.4 Technological                         

                                7.1.5 Legal                          

                                7.1.6 Environmental                      

                7.2 Porter’s Five analysis                                              

                                7.2.1 Bargaining Power of Suppliers                        

                                7.2.2 Bargaining Power of Consumers                    

                                7.2.3 Threat of New Entrants                     

                                7.2.4 Threat of Substitute Products and Services               

                                7.2.5 Competitive Rivalry within the Industry                      

8.Market Leaders' Analysis                                                          

                8.1 GE Healthcare                                           

                                8.1.1 Overview                

                                8.1.2 Product Analysis                   

                                8.1.3 Strategic Evaluation and Operations                            

                                8.1.4 Financial analysis                  

                                8.1.5 Legal issues                            

                                8.1.6 Recent Developments                       

                                8.1.7 SWOT analysis                       

                                8.1.8 Analyst View                          

                8.2 Hologic Inc.                                

                8.3 Segami Corporation                                

                8.4 Positron Corporation                                              

                8.5 Bracco Imaging S.P.A                                              

                8.6 Naviscan Inc.                                              

                8.7 Bayer Healthcare                                     

                8.8 Lantheus Medical Imaging Inc.                                           

                8.9 IBA Molecular Imaging                                           

                8.10 Medix Inc.                                

9.Competitive Landscape                                                            

                9.1 Market share analysis                                            

                9.2 Merger and Acquisition Analysis                                        

                9.3 Agreements, collaborations and Joint Ventures                                          

                9.4 New Product Launches                                          

10.Expert Opinions                                                         

                10.1 Market Outlook                                     

                10.2 Investment Opportunities                                 

Appendix                                                           

                a) List of Tables                                

                b) List of Figures                                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. Europe Nuclear Medicine Radiopharmaceuticals Market By Region, From 2015-2020 (USD Million)
  2. Europe Nuclear Medicine Radiopharmaceuticals Market By Type, From 2015-2020 (USD Million)
  3. Europe Diagnostic Radioisotopes Market By Region, From 2015-2020 (USD Million)
  4. Europe Therapeutic Radioisotopes Market By Region, From 2015-2020 (USD Million)
  5. Europe Nuclear Medicine Radiopharmaceuticals Market By Application, From 2015-2020 (USD Million)
  6. Europe Cardiology Market By Region, From 2015-2020 (USD Million)
  7. Europe Lymphoma Market By Region, From 2015-2020 (USD Million)
  8. Europe Thyroid Market By Region, From 2015-2020 (USD Million)
  9. Europe Neurology Market By Region, From 2015-2020 (USD Million)
  10. Europe Oncology Market By Region, From 2015-2020 (USD Million)
  11. Europe Other Applications Market By Region, From 2015-2020 (USD Million)
  12. Europe Diagnostic Radioisotopes Market By Type, From 2015-2020 ( USD Million )
  13. Europe SPECT Diagnostic Radioisotopes Market By Region, From 2015-2020 ( USD Million )
  14. Europe PET Diagnostic Radioisotopes Market By Region, From 2015-2020 ( USD Million )
  15. Europe Other Diagnostic Radioisotopes Market By Region, From 2015-2020 ( USD Million )
  16. Europe SPECT Diagnostic Radioisotopes Market By Type, From 2015-2020 ( USD Million )
  17. Europe Technetium-99m Market By Region, From 2015-2020 ( USD Million )
  18. Europe Thallium-201 Market By Region, From 2015-2020 ( USD Million )
  19. Europe Gallium-67 Market By Region, From 2015-2020 ( USD Million )
  20. Europe Iodine-23 Market By Region, From 2015-2020 ( USD Million )
  21. Europe Other SPECT Diagnostic Radioisotopes Market By Region, From 2015-2020 ( USD Million )
  22. Europe PET Diagnostic Radioisotopes Market By Type, From 2015-2020 ( USD Million )
  23. Europe Fluorine-18 Market By Region, From 2015-2020 ( USD Million )
  24. Europe Rubidium-82 Market By Region, From 2015-2020 ( USD Million )
  25. Europe Other PET Diagnostic Radioisotopes Market By Region, From 2015-2020 ( USD Million )
  26. Europe Therapeutic Radioisotopes Market By Type, From 2015-2020 ( USD Million )
  27. Europe Beta Emitters Market By Region, From 2015-2020 ( USD Million )
  28. Europe Alpha Emitters Market By Region, From 2015-2020 ( USD Million )
  29. Europe Brachytherapy Market By Region, From 2015-2020 ( USD Million )
  30. Europe Beta Emitters Market By Type, From 2015-2020 ( USD Million )
  31. Europe Iodine-131 Market By Region, From 2015-2020 ( USD Million )
  32. Europe Yttrium-90 Market By Region, From 2015-2020 ( USD Million )
  33. Europe Samarium-153 Market By Region, From 2015-2020 ( USD Million )
  34. Europe Rhenium-186 Market By Region, From 2015-2020 ( USD Million )
  35. Europe Lutetium-177 Market By Region, From 2015-2020 ( USD Million )
  36. Europe Alpha Emitters Market By Type, From 2015-2020 ( USD Million )
  37. Europe Radium-223 Market By Region, From 2015-2020 ( USD Million )
  38. Europe Other Alpha Emitters Market By Region, From 2015-2020 ( USD Million )
  39. Europe Brachytherapy Market By Type, From 2015-2020 ( USD Million )
  40. Europe Cesium-131 Market By Region, From 2015-2020 ( USD Million )
  41. Europe Iodine-125 Market By Region, From 2015-2020 ( USD Million )
  42. Europe Palladium-103 Market By Region, From 2015-2020 ( USD Million )
  43. Europe Iridium-192 Market By Region, From 2015-2020 ( USD Million )
  44. U.K Nuclear Medicine Radiopharmaceuticals Market By Type, From 2015-2020 (USD Million)
  45. U.K Nuclear Medicine Radiopharmaceuticals Market By Application, From 2015-2020 (USD Million)
  46. Spain Nuclear Medicine Radiopharmaceuticals Market By Type, From 2015-2020 (USD Million)
  47. Spain Nuclear Medicine Radiopharmaceuticals Market By Application, From 2015-2020 (USD Million)
  48. Germany Nuclear Medicine Radiopharmaceuticals Market By Type, From 2015-2020 (USD Million)
  49. Germany Nuclear Medicine Radiopharmaceuticals Market By Application, From 2015-2020 (USD Million)
  50. Italy Nuclear Medicine Radiopharmaceuticals Market By Type, From 2015-2020 (USD Million)
  51. Italy Nuclear Medicine Radiopharmaceuticals Market By Application, From 2015-2020 (USD Million)
  52. France Nuclear Medicine Radiopharmaceuticals Market By Type, From 2015-2020 (USD Million)
  53. France Nuclear Medicine Radiopharmaceuticals Market By Application, From 2015-2020 (USD Million)
  54. U.K Diagnostic Radioisotopes Market By Type, From 2015-2020 ( USD Million )
  55. Spain Diagnostic Radioisotopes Market By Type, From 2015-2020 ( USD Million )
  56. Germany Diagnostic Radioisotopes Market By Type, From 2015-2020 ( USD Million )
  57. Italy Diagnostic Radioisotopes Market By Type, From 2015-2020 ( USD Million )
  58. France Diagnostic Radioisotopes Market By Type, From 2015-2020 ( USD Million )
  59. U.K SPECT Diagnostic Radioisotopes Market By Type, From 2015-2020 ( USD Million )
  60. Spain SPECT Diagnostic Radioisotopes Market By Type, From 2015-2020 ( USD Million )
  61. Germany SPECT Diagnostic Radioisotopes Market By Type, From 2015-2020 ( USD Million )
  62. Italy SPECT Diagnostic Radioisotopes Market By Type, From 2015-2020 ( USD Million )
  63. France SPECT Diagnostic Radioisotopes Market By Type, From 2015-2020 ( USD Million )
  64. U.K PET Diagnostic Radioisotopes Market By Type, From 2015-2020 ( USD Million )
  65. Spain PET Diagnostic Radioisotopes Market By Type, From 2015-2020 ( USD Million )
  66. Germany PET Diagnostic Radioisotopes Market By Type, From 2015-2020 ( USD Million )
  67. Italy PET Diagnostic Radioisotopes Market By Type, From 2015-2020 ( USD Million )
  68. France PET Diagnostic Radioisotopes Market By Type, From 2015-2020 ( USD Million )
  69. U.K Therapeutic Radioisotopes Market By Type, From 2015-2020 ( USD Million )
  70. Spain Therapeutic Radioisotopes Market By Type, From 2015-2020 ( USD Million )
  71. Germany Therapeutic Radioisotopes Market By Type, From 2015-2020 ( USD Million )
  72. Italy Therapeutic Radioisotopes Market By Type, From 2015-2020 ( USD Million )
  73. France Therapeutic Radioisotopes Market By Type, From 2015-2020 ( USD Million )
  74. U.K Beta Emitters Market By Type, From 2015-2020 ( USD Million )
  75. Spain Beta Emitters Market By Type, From 2015-2020 ( USD Million )
  76. Germany Beta Emitters Market By Type, From 2015-2020 ( USD Million )
  77. Italy Beta Emitters Market By Type, From 2015-2020 ( USD Million )
  78. France Beta Emitters Market By Type, From 2015-2020 ( USD Million )
  79. U.K Alpha Emitters Market By Type, From 2015-2020 ( USD Million )
  80. Spain Alpha Emitters Market By Type, From 2015-2020 ( USD Million )
  81. Germany Alpha Emitters Market By Type, From 2015-2020 ( USD Million )
  82. Italy Alpha Emitters Market By Type, From 2015-2020 ( USD Million )
  83. France Alpha Emitters Market By Type, From 2015-2020 ( USD Million )
  84. U.K Brachytherapy Market By Type, From 2015-2020 ( USD Million )
  85. Spain Brachytherapy Market By Type, From 2015-2020 ( USD Million )
  86. Germany Brachytherapy Market By Type, From 2015-2020 ( USD Million )
  87. Italy Brachytherapy Market By Type, From 2015-2020 ( USD Million )
  88. France Brachytherapy Market By Type, From 2015-2020 ( USD Million )
Middle East And Africa Surface Plasmon Resonance Market By Product (Imaging System, Sensor System And Reagent) By Application (Drug Discovery, Material Sciences, Biosensor) – Industry Analysis, Size, Share, Growth...
Latin America Surface Plasmon Resonance Market By Product (Imaging System, Sensor System And Reagent) By Application (Drug Discovery, Material Sciences, Biosensor) –Latin America Industry Analysis, Size, Share, Gr...
Asia Pacific Surface Plasmon Resonance Market By Product (Imaging System, Sensor System And Reagent) By Application (Drug Discovery, Material Sciences, Biosensor) – Industry Analysis, Size, Share, Growth, Trends, ...
Europe Surface Plasmon Resonance Market By Product (Imaging System, Sensor System And Reagent) By Application (Drug Discovery, Material Sciences, Biosensor) – Industry Analysis, Size, Share, Growth, Trends, And Fo...
North America Surface Plasmon Resonance Market By Product (Imaging System, Sensor System And Reagent) By Application (Drug Discovery, Material Sciences, Biosensor) – Industry Analysis, Size, Share, Growth, Trends,...
Surface Plasmon Resonance Market By Product (Sensor System And Reagent , Imaging System) By Application (Material Sciences, Drug Discovery, Biosensor), And By Region - Global Industry Analysis, Size, Share, Growth, ...
Middle East And Africa Blood Brain Barrier Technologies Market By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2016–2021)...
Latin America Blood Brain Barrier Technologies Market By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2016–2021)...
Asia Pacific Blood Brain Barrier Technologies Market By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2016–2021)...
Europe Blood Brain Barrier Technologies Market By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2016–2021)...
North America Blood Brain Barrier Technologies Market By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2016–2021)...
Blood Brain Barrier Technologies Market By Region - Global Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2016–2021)...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2017 Market Data Forecast
All Rights Reserved.